glp-1 for ckd and the kidney: from physiology to pharmacology and outcomes in diabetes CKJ REVIEW GLP-1 receptor agonists
Description
N Engl J Med (2016) 375(19):183444
415417 GLP-1RAs can exert their local effects by activating vagal dendritic terminals that innervate the gut
Left untreated, the damage may result in vision loss
Structure and pancreatic expression of the insulin and glucagon genes
Intraperitoneal Injections: Administered into the peritoneal cavity surrounding abdominal organs, these are often used in specific cancer treatments and dialysis procedures
Tirzepatide Tirzepatide is a dual-action medication (GLP-1 and GIP) that many patients find especially effective for appetite control and weight loss
